Posted to News on 8th Nov 2021, 00:00
Watson-Marlow announces details of new US manufacturing facility
Watson-Marlow is pleased to announce that construction has begun on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022. The new facility will be dedicated to Watson-Marlow’s range of industry leading products, including peristaltic pumps, tubing, fluid path solutions and BioPure components.
Located in Devens, Massachusetts, USA, the 150,000 square foot (14,000 square metres) facility will be close to the life sciences hub in the Cambridge/Boston area. The site will incorporate a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing and offices, with space for two further cleanrooms within the initial footprint. With segregated cleanroom and non-cleanroom production capabilities, Watson-Marlow’s new US facility will strengthen the support the Company provides to customers in the region across its core sectors of pharmaceutical and biotechnology, medical diagnostics, and process industries.
“The new US facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region,” says Andrew Mines, Watson-Marlow managing director. “This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water. Together we will continue to develop market-leading fluid management solutions to engineer a more sustainable future.”
